Safety and Effectiveness of GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Liver Transplant Recipients with Diabetes
{{output}}
Background: We studied the safety and effectiveness of glucagon-like peptide-1 receptor agonists (GLP1-RAs) and sodium-glucose co-transporter-2 inhibitors (SGLT2is) in liver transplant recipients with diabetes. ... ...
